Article Versions Notes

Papanota A-M, Tsiakanikas P, Kontos CK, Malandrakis P, Liacos C-I, Ntanasis-Stathopoulos I, Kanellias N, Gavriatopoulou M, Kastritis E, Avgeris M, et al. A Molecular Signature of Circulating MicroRNA Can Predict Osteolytic Bone Disease in Multiple Myeloma. Cancers. 2021; 13(15):3877. https://doi.org/10.3390/cancers13153877

Papanota, Aristea-Maria, Panagiotis Tsiakanikas, Christos K. Kontos, Panagiotis Malandrakis, Christine-Ivy Liacos, Ioannis Ntanasis-Stathopoulos, Nikolaos Kanellias, Maria Gavriatopoulou, Efstathios Kastritis, Margaritis Avgeris, and et al. 2021. "A Molecular Signature of Circulating MicroRNA Can Predict Osteolytic Bone Disease in Multiple Myeloma" Cancers 13, no. 15: 3877. https://doi.org/10.3390/cancers13153877

Papanota, A.-M., Tsiakanikas, P., Kontos, C. K., Malandrakis, P., Liacos, C.-I., Ntanasis-Stathopoulos, I., Kanellias, N., Gavriatopoulou, M., Kastritis, E., Avgeris, M., Dimopoulos, M.-A., Scorilas, A., & Terpos, E. (2021). A Molecular Signature of Circulating MicroRNA Can Predict Osteolytic Bone Disease in Multiple Myeloma. Cancers, 13(15), 3877. https://doi.org/10.3390/cancers13153877